Bank of America Corporation reiterated their underperform rating on shares of Vitamin Shoppe, Inc (NYSE:VSI) in a report published on Wednesday. Bank of America Corporation currently has a $5.00 price objective on the specialty retailer’s stock, down from their prior price objective of $5.50.

A number of other equities research analysts have also weighed in on the company. Zacks Investment Research lowered Vitamin Shoppe from a hold rating to a sell rating in a research report on Tuesday, August 15th. TheStreet lowered Vitamin Shoppe from a c- rating to a d rating in a research report on Wednesday, August 9th. Morgan Stanley set a $8.00 price objective on Vitamin Shoppe and gave the stock a hold rating in a research report on Thursday, August 10th. Goldman Sachs Group, Inc. (The) reiterated a sell rating and issued a $6.00 price objective (down from $13.00) on shares of Vitamin Shoppe in a research report on Thursday, August 10th. Finally, Deutsche Bank AG reiterated a hold rating and issued a $7.00 price objective (down from $14.00) on shares of Vitamin Shoppe in a research report on Thursday, August 10th. Four research analysts have rated the stock with a sell rating and seven have given a hold rating to the company. The company has an average rating of Hold and a consensus target price of $14.38.

Shares of Vitamin Shoppe (VSI) opened at 5.50 on Wednesday. Vitamin Shoppe has a 12 month low of $5.30 and a 12 month high of $28.41. The firm’s market capitalization is $127.73 million. The company has a 50 day moving average of $8.98 and a 200-day moving average of $14.78.

Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings data on Wednesday, August 9th. The specialty retailer reported $0.23 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.39 by $0.16. The business had revenue of $304.84 million during the quarter, compared to the consensus estimate of $314.74 million. Vitamin Shoppe had a positive return on equity of 8.33% and a negative net margin of 11.98%. Vitamin Shoppe’s quarterly revenue was down 8.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.55 earnings per share. Analysts predict that Vitamin Shoppe will post $0.79 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This article was first posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this article on another domain, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this article can be read at https://theolympiareport.com/2017/08/27/vitamin-shoppe-inc-vsi-stock-rating-reaffirmed-by-bank-of-america-corporation.html.

Large investors have recently added to or reduced their stakes in the stock. BNP Paribas Arbitrage SA raised its stake in Vitamin Shoppe by 2.1% in the second quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock valued at $108,000 after buying an additional 192 shares in the last quarter. Municipal Employees Retirement System of Michigan raised its stake in Vitamin Shoppe by 18.1% in the second quarter. Municipal Employees Retirement System of Michigan now owns 9,410 shares of the specialty retailer’s stock valued at $110,000 after buying an additional 1,440 shares in the last quarter. Mason Street Advisors LLC raised its stake in Vitamin Shoppe by 7.0% in the first quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock valued at $112,000 after buying an additional 366 shares in the last quarter. Wolverine Trading LLC purchased a new stake in Vitamin Shoppe during the second quarter valued at $131,000. Finally, UBS Asset Management Americas Inc. raised its stake in Vitamin Shoppe by 17,041.4% in the second quarter. UBS Asset Management Americas Inc. now owns 11,999 shares of the specialty retailer’s stock valued at $140,000 after buying an additional 11,929 shares in the last quarter.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Analyst Recommendations for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.